|
Jul 30
|
Zacks Industry Outlook Highlights Moderna, Sarepta Therapeutics, Halozyme Therapeutics, Krystal Biotech and Axsome Therapeutics
|
|
Jul 26
|
Krystal Biotech to Report Second Quarter 2024 Financial Results on August 5, 2024
|
|
Jun 21
|
Krystal Biotech (KRYS) Surged as it Beat the Streat Estimates with Wide Margin
|
|
Jun 17
|
3 US Growth Companies With High Insider Ownership And Up To 96% Earnings Growth
|
|
May 17
|
3 High Insider Ownership US Stocks With Up To 55% Revenue Growth
|
|
May 15
|
Krystal Biotech to Present at the American Thoracic Society 2024 International Conference
|
|
May 8
|
Krystal Biotech to Present at BofA Securities 2024 Health Care Conference
|
|
May 7
|
Krystal Biotech, Inc. (NASDAQ:KRYS) Q1 2024 Earnings Call Transcript
|
|
May 7
|
Krystal Biotech Inc (KRYS) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and ...
|
|
May 7
|
Q1 2024 Krystal Biotech Inc Earnings Call
|
|
May 6
|
Krystal Biotech Inc (KRYS) Surpasses Revenue Estimates in Q1 2024
|
|
May 6
|
Krystal Biotech, Inc. (KRYS) Q1 Earnings and Revenues Miss Estimates
|
|
May 6
|
Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates
|
|
May 3
|
Why Krystal Biotech (KRYS) Might Surprise This Earnings Season
|
|
May 2
|
Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
|
|
Apr 26
|
Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024
|
|
Apr 23
|
Down -7.21% in 4 Weeks, Here's Why Krystal Biotech (KRYS) Looks Ripe for a Turnaround
|
|
Apr 22
|
Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung
|
|
Apr 17
|
Krystal Biotech (KRYS) is on the Move, Here's Why the Trend Could be Sustainable
|
|
Apr 15
|
Recent 3.8% pullback isn't enough to hurt long-term Krystal Biotech (NASDAQ:KRYS) shareholders, they're still up 437% over 5 years
|